Cargando…

Structure-guided optimisation of N-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α

The human 2-oxoglutarate (2OG)- and Fe(ii)-dependent oxygenases factor inhibiting hypoxia-inducible factor-α (FIH) and HIF-α prolyl residue hydroxylases 1–3 (PHD1–3) regulate the response to hypoxia in humans via catalysing hydroxylation of the α-subunits of the hypoxia-inducible factors (HIFs). Sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corner, Thomas P., Teo, Ryan Z. R., Wu, Yue, Salah, Eidarus, Nakashima, Yu, Fiorini, Giorgia, Tumber, Anthony, Brasnett, Amelia, Holt-Martyn, James P., Figg, William D., Zhang, Xiaojin, Brewitz, Lennart, Schofield, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631261/ https://www.ncbi.nlm.nih.gov/pubmed/37969593 http://dx.doi.org/10.1039/d3sc04253g

Ejemplares similares

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5
por: Tumber, Anthony, et al.
Publicado: (2023)

2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
por: Nakashima, Yu, et al.
Publicado: (2021)

Fluorinated derivatives of pyridine-2,4-dicarboxylate are potent inhibitors of human 2-oxoglutarate dependent oxygenases
por: Brewitz, Lennart, et al.
Publicado: (2021)

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease
por: Thun‐Hohenstein, Siegfried T. D., et al.
Publicado: (2021)

5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5
por: Brewitz, Lennart, et al.
Publicado: (2023)

Human Oxygenase Variants Employing a Single Protein Fe(II) Ligand Are Catalytically Active
por: Brasnett, Amelia, et al.
Publicado: (2021)

Synthesis of Novel Pyridine‐Carboxylates as Small‐Molecule Inhibitors of Human Aspartate/Asparagine‐β‐Hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Kinetic parameters of human aspartate/asparagine–β-hydroxylase suggest that it has a possible function in oxygen sensing
por: Brewitz, Lennart, et al.
Publicado: (2020)

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine
por: Malla, Tika R., et al.
Publicado: (2022)

Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

Author Correction: Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation
por: Brewitz, Lennart, et al.
Publicado: (2022)

Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M(pro) inhibitors
por: Malla, Tika R., et al.
Publicado: (2021)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
por: Holt-Martyn, James P., et al.
Publicado: (2019)

In vitro selection of macrocyclic peptide inhibitors containing cyclic γ(2,4)-amino acids targeting the SARS-CoV-2 main protease
por: Miura, Takashi, et al.
Publicado: (2023)

Substrate selectivity and inhibition of histidine JmjC hydroxylases MINA53 and NO66
por: Türkmen, Vildan A., et al.
Publicado: (2023)

Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
por: Figg, William D., et al.
Publicado: (2021)

Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6
por: Cockman, Matthew E., et al.
Publicado: (2022)

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease
por: Brewitz, Lennart, et al.
Publicado: (2022)

Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
por: Holt‐Martyn, James P., et al.
Publicado: (2019)

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
por: Brewitz, Lennart, et al.
Publicado: (2023)

Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
por: Chan, Mun Chiang, et al.
Publicado: (2015)

Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
por: Chan, Mun Chiang, et al.
Publicado: (2016)

Formaldehyde reacts with N-terminal proline residues to give bicyclic aminals
por: John, Tobias, et al.
Publicado: (2023)

Lessons from LIMK1 enzymology and their impact on inhibitor design
por: Salah, Eidarus, et al.
Publicado: (2019)

αβ,α′β′-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes
por: de Munnik, Mariska, et al.
Publicado: (2023)

Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor
por: England, Katherine S., et al.
Publicado: (2014)

The Rhesus Factors—II: Haemolytic Disease of the New-Born
por: Corner, Beryl D.
Publicado: (1947)

Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern
por: Pfeffer, Inga, et al.
Publicado: (2019)

Inhibitors of both the N-methyl lysyl- and arginyl-demethylase activities of the JmjC oxygenases
por: Bonnici, Joanna, et al.
Publicado: (2018)

Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors
por: Shishodia, Shifali, et al.
Publicado: (2021)

Optimised amino acid specific weighting factors for unbound protein docking
por: Heuser, Philipp, et al.
Publicado: (2006)

Optimisation of External Factors for the Growth of Francisella novicida within Dictyostelium discoideum
por: Kelava, Ina, et al.
Publicado: (2020)

Human histone demethylase KDM6B can catalyse sequential oxidations
por: Hopkinson, Richard J., et al.
Publicado: (2018)

Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor
por: Tarhonskaya, Hanna, et al.
Publicado: (2015)

Practical Implementation of the Comprehensive Geriatric Assessment to Optimise Care for Older Adults with Cancer
por: Tack, Laura, et al.
Publicado: (2023)

First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53
por: Nowak, Radosław P., et al.
Publicado: (2021)

Mindfulness for people with chronic pain: Factors affecting engagement and suggestions for programme optimisation
por: Marikar Bawa, Fathima L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_11j04jttnt0gtfa0cc0f60r24l